Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT03157635 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03157635
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-14
- Primary completion
- 2026-08-13
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.